- Make in U.S. by August 2028 or pay up to 200% duty, Trump tells generic drugmakers The Hindu
- Trump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines The Times of India
- Manufacturing in US impossible: Pharma exporters The New Indian Express
- Indias Generic Drug Exports Now Face New US Tariff Threat TheWire.in
- Tariffs Alone Will Not Produce Sustainable Generic Medicine In US: IPA Deccan Chronicle